Private company

Pontifax Management 4 G.P. (2015) Ltd.

Last updated Oct 21, 2026.

Overview

HeadquartersL3¹

See how the biggest companies compare on our leaderboards

Corporate structure

Pontifax Management 4 G.P. (2015) Ltd. sits at the top of its group. 6 entities, 1 country on record. Switch between the flow chart and the network, and select any entity to see its details.

Pontifax Management 4 G.P. (2015) Ltd. L3
- AgomAb Therapeutics NV Stake · C9
- Climb Bio, Inc. Stake · Wellesley Hills, Massachusetts
- Keros Therapeutics, Inc. Stake · Lexington, Massachusetts
- LB PHARMACEUTICALS INC Stake · New York, New York
- Nuvectis Pharma, Inc. Stake · Fort Lee, New Jersey

Built from major holders from Schedules 13D and 13G; stakes of 5% or more it reported on Schedules 13D and 13G (5 companies). Each entity in the chart links to its source.

Stakes it holds

Pontifax Management 4 G.P. (2015) Ltd. has told the SEC it owns more than 5% of 5 companies, latest first (Schedules 13D and 13G).

AgomAb Therapeutics NVSCHEDULE 13G Apr 16, 2026²
Keros Therapeutics, Inc.SCHEDULE 13D/A Apr 18, 2025 to Oct 16, 2025³
LB PHARMACEUTICALS INCSCHEDULE 13D Sep 25, 2025⁴
Climb Bio, Inc.SCHEDULE 13G Sep 18, 2025⁵
Nuvectis Pharma, Inc.SC 13G/A Feb 6, 2024 to Nov 5, 2024⁶

Sources

The numbers on this page point here. Each one links to the record it came from.